Lutembacher's syndrome percutaneous approach

Jump to navigation Jump to search

Lutembacher's syndrome Microchapters

Home

Overview

Historical Perspective

Pathophysiology

Epidemiology and Demographics

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Electrocardiogram

X-Ray

Echocardiography

Treatment

Percutaneous Approach

Surgical Approach

Case Studies

Case #1

Lutembacher's syndrome percutaneous approach On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Lutembacher's syndrome percutaneous approach

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Lutembacher's syndrome percutaneous approach

CDC on Lutembacher's syndrome percutaneous approach

Lutembacher's syndrome percutaneous approach in the news

Blogs on Lutembacher's syndrome percutaneous approach

Directions to Hospitals Treating Lutembacher's syndrome

Risk calculators and risk factors for Lutembacher's syndrome percutaneous approach

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ayokunle Olubaniyi, M.B,B.S

Overview

Percutaneous approach

Traditionally, Lutembacher's syndrome has been treated surgically.[1] Nowadays, it can be treated with percutaneous transcathetar mitral commissurotomy (PTMC) using the Inoue balloon.[2] The Inoue technique has become the procedure of choice around the world with excellent long term results.[3] The atrial septal defect was closed with an Amplatzer atrial septal occluder under transthoracic echocardiography (TTE) guidance without general anesthesia.[2] By combining these two techniques in the same patient at the same cardiac catheterization, percutaneous management of Lutembacher's syndrome can obviate the morbidity and mortality associated with cardiac surgery, the psychological trauma of a thoracotomy scar, the prolonged hospital stay followed by another prolonged period of home convalescence and the possibility of repeat thoracotomy for mitral restenosis.[1]

References

  1. 1.0 1.1 Cheng TO (1999). "Coexistent atrial septal defect and mitral stenosis (Lutembacher's syndrome): An ideal combination for percutaneous treatment". Catheter Cardiovasc Interv. 48 (2): 205–6. PMID 10506781.
  2. 2.0 2.1 Shabbir M, Ahmed W, Akhtar K (2008). "Transcatheter treatment of Lutembacher's syndrome". J Coll Physicians Surg Pak. 18 (2): 105–6. doi:02.2008/JCPSP.105106 Check |doi= value (help). PMID 18454897.
  3. Chen CR, Cheng TO (1995). "Percutaneous balloon mitral valvuloplasty by the Inoue technique: a multicenter study of 4832 patients in China". Am Heart J. 129 (6): 1197–203. PMID 7754954.


Template:WikiDoc Sources